WM (NYSE: WM) reported Q3 EPS of $1.98, $0.05 worse than the analyst estimate of $2.03. Revenue for the quarter came in at $6.44 billion versus the consensus estimate of $6.5 billion.

The Company is confident in its ability to deliver upon its full-year outlook ranges for adjusted operating EBITDA and free cash flow.

The Company is affirming its adjusted operating EBITDA guidance of between $7.475 and $7.625 billion.(a)
Free cash flow guidance remains between $2.8 and $2.9 billion.(a)
Total Company revenue is now expected to be approximately $25.275 billion, which is at the low end of the Company’s prior guidance range. The decrease from prior expectations is primarily related to a further decline in recycled commodity pricing as well as modestly lower revenue expectations from WM Healthcare Solutions.(h)
Projected adjusted operating EBITDA margin guidance has increased to between 29.6% and 30.2% from between 29.6% and 29.9% .(a)

For earnings history and earnings-related data on WM (WM) click here.